Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Partnership to Launch Wireless Brain Research System

By LabMedica International staff writers
Posted on 07 Jan 2015
Neuroscience research is now going wireless with the use of a new neural activity monitoring system.

Blackrock Microsystems, LLC (Salt Lake City, UT, USA) reported that it has established an agreement with Brown University (Providence, RI, USA) to license and market a wireless neural activity monitoring system that will free neuroscientists from the burdensome wires and cables that have hampered their research efforts for years. More...


The technology was described online December 4, 2014, in the journal Neuron. The wireless neurosensory, developed by the neuroengineering laboratory at Brown University, was found to substantially outperform all other wireless sensors currently on the market. Senior author Arto Nurmikko commented, “This device enables new types of neuroscience experiments with vast amounts of brain data wirelessly and continuously streamed from brain microcircuits.”

Blackrock first presented the system at the Society for Neuroscience’s annual meeting in Washington DC (USA), held in November 2014. The Blackrock system, which includes Brown’s technology, can transmit large amounts of data—via 96 channels at 48 Mbps—from a subject’s brain for up to 48 hours between rechargeable battery replacements. Furthermore, at only 43 g and 60 cubic centimeters, it is more compact than any other wireless brain technology.

Traditional wired neuroscience research systems restrict a person’s movement and make it tremendously hard for researchers to study sleep. Blackrock’s new wireless system eliminates such problems. “This wireless system is a major step forward in brain-interface technology,” said Prof. Florian Solzbacher, PhD, president of Blackrock Microsystems. “We’re working hard to make this technology smaller and longer-lasting. These systems can have every-day, practical uses for people, and we’re determined to make that a reality.”

Blackrock Microsystems is a world-leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology is focused on worldwide the latest advances in brain machine interfaces, implantable bionic technologies, and epilepsy diagnostics.

Related Links:

Blackrock Microsystems
Brown University



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.